These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 7685118)
21. Insulin and insulin-like growth factors stimulate in vivo receptor autophosphorylation and tyrosine phosphorylation of a 70K substrate in cultured fetal chick neurons. Kenner KA; Heidenreich KA Endocrinology; 1991 Jul; 129(1):301-11. PubMed ID: 1711464 [TBL] [Abstract][Full Text] [Related]
22. Differential phosphorylation of IRS-1 by insulin and insulin-like growth factor I receptors in Chinese hamster ovary cells. Amoui M; Craddock BP; Miller WT J Endocrinol; 2001 Oct; 171(1):153-62. PubMed ID: 11572799 [TBL] [Abstract][Full Text] [Related]
23. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells. Kim B; Leventhal PS; White MF; Feldman EL Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424 [TBL] [Abstract][Full Text] [Related]
25. Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells. Wang LM; Keegan AD; Li W; Lienhard GE; Pacini S; Gutkind JS; Myers MG; Sun XJ; White MF; Aaronson SA Proc Natl Acad Sci U S A; 1993 May; 90(9):4032-6. PubMed ID: 7683417 [TBL] [Abstract][Full Text] [Related]
26. Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells. Byron SA; Horwitz KB; Richer JK; Lange CA; Zhang X; Yee D Br J Cancer; 2006 Nov; 95(9):1220-8. PubMed ID: 17043687 [TBL] [Abstract][Full Text] [Related]
28. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells. Guvakova MA; Surmacz E Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064 [TBL] [Abstract][Full Text] [Related]
29. Transactivation of the IGF-1R by aldosterone. Holzman JL; Liu L; Duke BJ; Kemendy AE; Eaton DC Am J Physiol Renal Physiol; 2007 Apr; 292(4):F1219-28. PubMed ID: 17190911 [TBL] [Abstract][Full Text] [Related]
30. Antiinsulin receptor autoantibodies induce insulin receptors to constitutively associate with insulin receptor substrate-1 and -2 and cause severe cell resistance to both insulin and insulin-like growth factor I. Auclair M; Vigouroux C; Desbois-Mouthon C; Deibener J; Kaminski P; Lascols O; Cherqui G; Capeau J; Caron M J Clin Endocrinol Metab; 1999 Sep; 84(9):3197-206. PubMed ID: 10487687 [TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor-I-induced DNA synthesis in insulin-secreting cell line RINm5F is associated with phosphorylation of the insulin-like growth factor-I receptor and the insulin receptor substrate-2. Zhang Q; Berggren PO; Hansson A; Tally M J Endocrinol; 1998 Mar; 156(3):573-81. PubMed ID: 9582514 [TBL] [Abstract][Full Text] [Related]
32. Insulin receptor substrate 4 supports insulin- and interleukin 4-stimulated proliferation of hematopoietic cells. Fantin VR; Keller SR; Lienhard GE; Wang LM Biochem Biophys Res Commun; 1999 Jul; 260(3):718-23. PubMed ID: 10403832 [TBL] [Abstract][Full Text] [Related]
33. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways. Sasaoka T; Ishiki M; Sawa T; Ishihara H; Takata Y; Imamura T; Usui I; Olefsky JM; Kobayashi M Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504 [TBL] [Abstract][Full Text] [Related]
34. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals. Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243 [TBL] [Abstract][Full Text] [Related]
35. Differential roles of insulin receptor substrates in the anti-apoptotic function of insulin-like growth factor-1 and insulin. Tseng YH; Ueki K; Kriauciunas KM; Kahn CR J Biol Chem; 2002 Aug; 277(35):31601-11. PubMed ID: 12082100 [TBL] [Abstract][Full Text] [Related]
36. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines. Jackson JG; Zhang X; Yoneda T; Yee D Oncogene; 2001 Nov; 20(50):7318-25. PubMed ID: 11704861 [TBL] [Abstract][Full Text] [Related]
38. Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. Saad MJ; Folli F; Kahn JA; Kahn CR J Clin Invest; 1993 Oct; 92(4):2065-72. PubMed ID: 7691892 [TBL] [Abstract][Full Text] [Related]
39. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2. Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936 [TBL] [Abstract][Full Text] [Related]
40. Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo. Giorgino F; Almahfouz A; Goodyear LJ; Smith RJ J Clin Invest; 1993 May; 91(5):2020-30. PubMed ID: 7683695 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]